Evidence map›Paper›PMID 39781293›Full record

ArticleMedComm2025

Novel antibiotics against

She Pengfei, Yang Yifan, Li Linhui, Li Yimin, Xiao Dan, Guo Shaowei, Huang Guanqing, Wu Yong

Abstract read
In one paragraph

Article in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Drug repurposing of Nifuratel against methicillin-resistantFrontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

She PengfeiDepartment of Laboratory Medicine The Third Xiangya Hospital of Central South University Changsha Hunan China.
Yang YifanDepartment of Laboratory Medicine The Third Xiangya Hospital of Central South University Changsha Hunan China.
Li LinhuiDepartment of Laboratory Medicine The Third Xiangya Hospital of Central South University Changsha Hunan China.
Li YiminDepartment of Laboratory Medicine The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha) Central South University Changsha Hunan China.
Xiao DanDepartment of Laboratory Medicine The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha) Central South University Changsha Hunan China.
Guo ShaoweiDepartment of Laboratory Medicine The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha) Central South University Changsha Hunan China.
Huang GuanqingDepartment of Laboratory Medicine The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha) Central South University Changsha Hunan China.
Wu YongDepartment of Laboratory Medicine The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha) Central South University Changsha Hunan China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increased prevalence of methicillin-resistant

Indexed as

antibiotic developmentbiofilmFtsHin vivomethicillin‐resistant Staphylococcus aureusproton motive force

Identifiers

PMID39781293
PMCPMC11707430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.